Antibody against tumor necrosis factor-α reduces bortezomib-induced allodynia in a rat model

A Chiorazzi, A Canta, C Meregalli, V Carozzi… - Anticancer …, 2013 - ar.iiarjournals.org
Background: Bortezomib is an anti-neoplastic drug acting against multiple myeloma but its
use is associated with the onset of painful peripheral neuropathy. Tumor necrosis factor-α …

[PDF][PDF] Antibody Against Tumor Necrosis Factor-α Reduces Bortezomib-induced Allodynia in a Rat Model

A CHIORAZZI, A CANTA, C MEREGALLI… - ANTICANCER …, 2013 - academia.edu
Background: Bortezomib is an anti-neoplastic drug acting against multiple myeloma but its
use is associated with the onset of painful peripheral neuropathy. Tumor necrosis factor-α …

Antibody against tumor necrosis factor-α reduces bortezomib-induced allodynia in a rat model

A Chiorazzi, A Canta, C Meregalli… - Anticancer …, 2013 - pubmed.ncbi.nlm.nih.gov
Background Bortezomib is an anti-neoplastic drug acting against multiple myeloma but its
use is associated with the onset of painful peripheral neuropathy. Tumor necrosis factor-α …

Antibody against tumor necrosis factor-α reduces bortezomib-induced allodynia in a rat model.

A Chiorazzi, A Canta, C Meregalli, V Carozzi… - Anticancer …, 2013 - europepmc.org
Background Bortezomib is an anti-neoplastic drug acting against multiple myeloma but its
use is associated with the onset of painful peripheral neuropathy. Tumor necrosis factor-α …

Antibody Against Tumor Necrosis Factor-α Reduces Bortezomib-induced Allodynia in a Rat Model

A Chiorazzi, A Canta, C Meregalli, V Carozzi… - ANTICANCER …, 2013 - boa.unimib.it
Bortezomib is an anti-neoplastic drug acting against multiple myeloma but its use is
associated with the onset of painful peripheral neuropathy. Tumor necrosis factor-α (TNFα) …

[PDF][PDF] Antibody Against Tumor Necrosis Factor-α Reduces Bortezomib-induced Allodynia in a Rat Model

A CHIORAZZI, A CANTA, C MEREGALLI… - ANTICANCER …, 2013 - ar.iiarjournals.org
Background: Bortezomib is an anti-neoplastic drug acting against multiple myeloma but its
use is associated with the onset of painful peripheral neuropathy. Tumor necrosis factor-α …